Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
11.21
-0.39 (-3.36%)
At close: Jan 17, 2025, 4:00 PM
10.80
-0.41 (-3.66%)
After-hours: Jan 17, 2025, 4:00 PM EST
Pliant Therapeutics Employees
Pliant Therapeutics had 158 employees as of December 31, 2023. The number of employees increased by 34 or 27.42% compared to the previous year.
Employees
158
Change (1Y)
34
Growth (1Y)
27.42%
Revenue / Employee
n/a
Profits / Employee
-$1,276,462
Market Cap
682.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PLRX News
- 2 months ago - Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024 - GlobeNewsWire
- 3 months ago - Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs - GlobeNewsWire
- 4 months ago - Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Pliant Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 5 months ago - Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 - GlobeNewsWire
- 5 months ago - Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 7 months ago - Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors - GlobeNewsWire
- 8 months ago - Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™ - GlobeNewsWire